Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Impact of Myeloproliferative Neoplasms (MPNs) on Health-Related Quality of Life (HRQOL) and Medical Resource Utilization: Results from the MERGE Registry

Ali Taher, MD PhD, Mohamed A Yassin, Zhijian Xiao, Hsin-An Hou, MD PhD, Tulin Tuglular, MD, Vikram Mathews, MD, Gerd Rippin, Islam Sadek, Asif Siddiqui, PhD, Raymond S Wong, MBChB, MD

Blood (2018) 132 (Supplement 1): 4311.

https://doi.org/10.1182/blood-2018-99-113248

Published: 2018

Journal Articles

Myeloproliferative Neoplasms in Asia, Including Middle East, Turkey, and Algeria: Epidemiological Indices and Treatment Practice Patterns from the Multinational, Multicenter, Observational MERGE Registry

Mohamed A Yassin, Ali Taher, MD PhD, Vikram Mathews, MD, Hsin-An Hou, MD PhD, Tahir Shamsi, Tulin Tuglular, MD, Zhijian Xiao, Soo-Jeong Kim, MD, Depei Wu, MD PhD, Junmin Li, MD, Gerd Rippin, Islam Sadek, Asif Siddiqui, PhD, Raymond S Wong, MBChB, MD

Blood (2018) 132 (Supplement 1): 5461.

https://doi.org/10.1182/blood-2018-99-114416

Published: 2018

Journal Articles

GDF15 and Erythroferrone Mark Erythropoietic Response to ACE-011 (Sotatercept) in Thalassemia

Blood (2018) 132 (Supplement 1): 3633.

https://doi.org/10.1182/blood-2018-99-111770

Published: 2018

Journal Articles

Phase 2 Clinical Trial Results for Bitopertin, an Oral Glycine Transporter 1 Inhibitor, in Patients with Non-Transfusion Dependent Beta-Thalassemia

Ali Taher, MD PhD, Vip Viprakasit, MD DPhil, Maria Domenica Cappellini, MD, Dominik Kraus, PhD, Patrick Cech, PhD, Volz Dietmar, PhD, Erica Winter, PharmD, Norman Alan Mazer, MD PhD, Stephane Nave, MD, Juergen Dukart, PhD, Franziska Schaedeli Stark, PhD, Annette Koerner, PhD, Omar Khwaja, MD PhD, Ricardo Hermosilla, DVM, PhD

Blood (2018) 132 (Supplement 1): 3635.

https://doi.org/10.1182/blood-2018-99-114776

Published: 2018

Journal Articles

Effect of Ljpc-401 (synthetic human hepcidin) on Iron Parameters in Healthy Adults

John Porter, MA MD FRCP FRCPath, Kris Kowdley, MD, Ali Taher, MD PhD, Jeffrey Vacirca, MD, Zancong Shen, PhD, Steve Chen, MD, Lakhmir Chawla, MD, George Tidmarsh, MD PhD

Blood (2018) 132 (Supplement 1): 2336.

https://doi.org/10.1182/blood-2018-99-110885

Published: 2018

Journal Articles

Venous Thromboembolism and Preoperative Steroid Use, a Retrospective Cohort Study from the ACS-NSQIP Database: Are Surgical Patients at Risk?

Anthony Haddad, MD, Rami Kantar, MD, Hani Tamim, PhD, Faek R Jamali, MD, Ali Taher, MD, PhD

Blood (2014) 124 (21): 2865.

https://doi.org/10.1182/blood.V124.21.2865.2865

Published: 2014

Journal Articles

Multicenter Validation of Spin-Density Projection-Assisted R2-MRI for the Non-Invasive Measurement of Liver Iron Concentration

Timothy G St Pierre, PhD, Amal El-Beshlawy, MD, Mohsen Saleh Elalfy, MD, Abdullah Al Jefri, MD, Kusai Al Zir, MD, Shahina Daar, MD, Dany Habr, MD, Ulrike Kriemler-Krahn, Ali Taher, MD

Blood (2010) 116 (21): 2053.

https://doi.org/10.1182/blood.V116.21.2053.2053

Published: 2010

Journal Articles

Geographical Differences In Transfusion and Iron Chelation Practices In 1558 Patients with Transfusion-Dependent Anemias

Vip Viprakasit, MD, DPhil, Norbert Gattermann, MD, Jong Wook Lee, MD, John B. Porter, MD, Ali Taher, MD, Dany Habr, MD, Bernard Roubert, PhD, Gabor Domokos, PhD, Maria Domenica Cappellini, MD

Blood (2010) 116 (21): 4272.

https://doi.org/10.1182/blood.V116.21.4272.4272

Published: 2010

Journal Articles

Continued Improvement and Normalization of Myocardial T2* In Patients with β-thalassemia Major Treated with Deferasirox (Exjade®) for up to 3 Years

Dudley Pennell, MD, John B. Porter, MD, Maria Domenica Cappellini, MD, Lee Lee Chan, MD, Amal El-Beshlawy, MD, Yesim Aydinok, MD, Hishamshah Ibrahim, MD, Chi-Kong Li, MD, Vip Viprakasit, MD, DPhil, Mohsen Saleh Elalfy, MD, Antonis Kattamis, MD, Gillian Smith, MSc, Dany Habr, MD, Gabor Domokos, PhD, Bernard Roubert, PhD, Ali Taher, MD

Blood (2010) 116 (21): 4276.

https://doi.org/10.1182/blood.V116.21.4276.4276

Published: 2010

Journal Articles

HQK-1001 Is Well Tolerated and Augments Hemoglobin F and Hemoglobin Levels In Patients with Beta Thalassemia Intermedia

Suthat Fuchareon, MD, Adlette C. Inati, MD, Noppadol Siritanaratkul, MD, Suzanne Koussa, MD, Ali Taher, MD, Michael S Boosalis, PhD, Swee Lay Thein, DSc, FRCP, MB, BS, FRCPath, Wayne Wallis, MD, Patrick Bobbitt, BS, Audrey Thomson, BSc, Elsa Johnson, MBA, Ronald J Berenson, MD, Susan P Perrine, MD

Blood (2010) 116 (21): 4280.

https://doi.org/10.1182/blood.V116.21.4280.4280

Published: 2010

Journal Articles

Iron Overload Diagnosis and Management Among Clinicians: International Survey Showing Gaps In Knowledge and Need for Continuing Educational Programs

Maria Domenica Cappellini, MD, Photis Beris, Pierre Brissot, MD, John B. Porter, MD, Ali Taher, MD, Patty Peterson, CCMEP, Elaine Rudell, CCMEP

Blood (2010) 116 (21): 2562.

https://doi.org/10.1182/blood.V116.21.2562.2562

Published: 2010

Journal Articles

Brain MRI Findings in Lebanese Sickle Cell Disease Patients.

Adlette Inati, MD, Youssef Rachkidi, MD, Ossama Jradi, MD, Rabih Wehbe, MD, Habib Moallem, PhD, Suzanne Koussa, MD, Ali Taher, MD

Blood (2007) 110 (11): 3794.

https://doi.org/10.1182/blood.V110.11.3794.3794

Published: 2007

Journal Articles

Differences in Fetal Hemoglobin Induction in Sickle Cell Disease and beta-Thalassemia.

Hassana Fathallah, PhD, Ali Taher, MD, Ali Bazarbachi, MD,PhD, George F. Atweh, MD

Blood (2006) 108 (11): 555.

https://doi.org/10.1182/blood.V108.11.555.555

Published: 2006

Journal Articles

Additive Effect of Butyrate and Hemin on Fetal Hemoglobin Induction in Erythroid Cells from Sickle Cell Disease and Beta-Thalassemia.

Hassana Fathallah, PhD, Ali Taher, MD, Ali Bazarbachi, MD,PhD, George F. Atweh, PhD

Blood (2006) 108 (11): 1224.

https://doi.org/10.1182/blood.V108.11.1224.1224

Published: 2006

Journal Articles

Effect of Zoledronic Acid on Bone Mineral Density in Thalassemia-Induced Osteoporosis: Results of a Phase II Clinical Trial.

Ali Taher, MD, Sami Azar, MD, Wael Shamseddeen, MD, MPH, Dany Habr, MD, Adlette Inati, MD, Suzane Koussa, MD, Rami Mahfouz, MD, Zaher Otrock, MD

Blood (2005) 106 (11): 3826.

https://doi.org/10.1182/blood.V106.11.3826.3826

Published: 2005

Journal Articles

Thalassemia Major, Intermedia & Sickle-Thal Patients in Lebanon.

Ali Taher, MD, Wael Shamseddeen, MD, MPH, Samir Arnaout, MD, Walid Gharzuddin, MD, Nabil Zeineh, MD, Samir Alam, MD, Hussein Isma’eel, MD

Blood (2005) 106 (11): 3827.

https://doi.org/10.1182/blood.V106.11.3827.3827

Published: 2005

Journal Articles

Study on Intravenous Zoledronic Acid Treatment in Thalassemia-Induced Osteoporosis.

Zaher Otrock, MD, Sami Azar, MD, Adlette Inati, MD, Suzane Koussa, MD, Rami Mahfouz, MD, Ali Taher, MD.

Blood (2004) 104 (11): 3764.

https://doi.org/10.1182/blood.V104.11.3764.3764

Published: 2004

Journal Articles

L-Carnitine and Apoptosis in Thalassemia Major Patients.

Ali Taher, MD, H. Seoud, MD, A. Ibrahim, MD, H. Gabre, MD, I. Youssry Ibrahim, MD, G. Abd ElGawada, MD, E. Aoun, MD, A. El-Beshlawy, MD

Blood (2004) 104 (11): 3767.

https://doi.org/10.1182/blood.V104.11.3767.3767

Published: 2004

Journal Articles

Study on Hepatitis C Treatment Using Ribavirin and Pegylated Interferon in Thalassemia Patients (SCRIPT): One Year Report.

Adlette Inati, MD, Ala Sharara, MD, Sandy Ghorra, PharmD, Elie Aoun, MD, Marwan Taha, PharmD, Suzanne Koussa, MD, Ali Taher, MD.

Blood (2004) 104 (11): 3768.

https://doi.org/10.1182/blood.V104.11.3768.3768

Published: 2004

Journal Articles

The Incidence of Thromboembolic Events among 8860 Patients with Thalassemia Major and Intermedia in the Mediterranean Area and Iran.

Ali Taher, MD, Ghassan Mehio, MD, Daniela Bignamini, MD, Antonios Kattamis, MD, Eliezer Rachmilewitz, MD, Maria Cappellini, MD

Blood (2004) 104 (11): 3623.

https://doi.org/10.1182/blood.V104.11.3623.3623

Published: 2004

NARROW

Impact of Myeloproliferative Neoplasms (MPNs) on Health-Related Quality of Life (HRQOL) and Medical Resource Utilization: Results from the MERGE Registry

Myeloproliferative Neoplasms in Asia, Including Middle East, Turkey, and Algeria: Epidemiological Indices and Treatment Practice Patterns from the Multinational, Multicenter, Observational MERGE Registry

GDF15 and Erythroferrone Mark Erythropoietic Response to ACE-011 (Sotatercept) in Thalassemia

Phase 2 Clinical Trial Results for Bitopertin, an Oral Glycine Transporter 1 Inhibitor, in Patients with Non-Transfusion Dependent Beta-Thalassemia

Effect of Ljpc-401 (synthetic human hepcidin) on Iron Parameters in Healthy Adults

Venous Thromboembolism and Preoperative Steroid Use, a Retrospective Cohort Study from the ACS-NSQIP Database: Are Surgical Patients at Risk?

Multicenter Validation of Spin-Density Projection-Assisted R2-MRI for the Non-Invasive Measurement of Liver Iron Concentration

Geographical Differences In Transfusion and Iron Chelation Practices In 1558 Patients with Transfusion-Dependent Anemias

Continued Improvement and Normalization of Myocardial T2* In Patients with β-thalassemia Major Treated with Deferasirox (Exjade®) for up to 3 Years

HQK-1001 Is Well Tolerated and Augments Hemoglobin F and Hemoglobin Levels In Patients with Beta Thalassemia Intermedia

Iron Overload Diagnosis and Management Among Clinicians: International Survey Showing Gaps In Knowledge and Need for Continuing Educational Programs

Brain MRI Findings in Lebanese Sickle Cell Disease Patients.

Differences in Fetal Hemoglobin Induction in Sickle Cell Disease and beta-Thalassemia.

Additive Effect of Butyrate and Hemin on Fetal Hemoglobin Induction in Erythroid Cells from Sickle Cell Disease and Beta-Thalassemia.

Effect of Zoledronic Acid on Bone Mineral Density in Thalassemia-Induced Osteoporosis: Results of a Phase II Clinical Trial.

Thalassemia Major, Intermedia & Sickle-Thal Patients in Lebanon.

Study on Intravenous Zoledronic Acid Treatment in Thalassemia-Induced Osteoporosis.

L-Carnitine and Apoptosis in Thalassemia Major Patients.

Study on Hepatitis C Treatment Using Ribavirin and Pegylated Interferon in Thalassemia Patients (SCRIPT): One Year Report.

The Incidence of Thromboembolic Events among 8860 Patients with Thalassemia Major and Intermedia in the Mediterranean Area and Iran.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only